期刊文献+

幽门螺杆菌感染对冠心病患者血脂和血浆高敏C反应蛋白的影响 被引量:24

The Effect of Helicobacter Pylori Infection on Plasma Lipid and High Sensitive C Reactive Protein Levels in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨冠心病患者幽门螺杆菌感染对血脂和血浆高敏C反应蛋白的影响,并探讨其可能的发病机制。方法对确诊的159例冠心病患者且近期无感染性疾病及慢性炎症性疾病,采用呼气试验来检测是否感染幽门螺杆菌,根据呼气试验将冠心病患者分为感染阴性组、轻度感染组和重度感染组,同时测定血浆高敏C反应蛋白、血尿酸、血纤维蛋白原和血脂水平。结果与感染阴性组患者比,幽门螺杆菌感染阳性组患者总胆固醇、低密度脂蛋白及高敏C反应蛋白水平明显升高,甘油三酯水平降低(P<0.05);重度感染组高敏C反应蛋白水平明显高于轻度感染组(P<0.05)。结论幽门螺杆菌感染可能通过影响脂质代谢,从而加重血管壁的炎症反应;在冠心病患者中,幽门螺杆菌感染阳性患者可能有更高的心血管事件发生。 Aim To investigate the effect of Helicobacter pylori (Hp) infection on plasma lipicl and high sensitive C reactive protein (hs-CRP) levels in patients with coronary heart disease (CHD). Methods 159 CHD patients were recruited for this study. And plasma fibrinegen, plasma lipid, plasma urine acid and hs-CRP were examined in all subjects. Expiratory test were executed in all subjects. All subjects were divided into negative infection group, slight infection group and serious in- fection group. Results In patients with Hp infection, plasma hs-CRP, total cholesterol (TC) and low density lipoprotein cholesterol (LDLC) were significantly higher, but triglyceride (TG) level was lower, compared with negative infection group (P〈0.05); Plasma hs-CRP was significantly higher in serious infection group than in slight infection group (P〈0.05). Conclusion Hp infection may increase vascular inflammatory reaction through lipid metabolic disturbance. There maybe have higher cardiovascular events rates in CHD patients with Hp infection.
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第5期389-391,共3页 Chinese Journal of Arteriosclerosis
关键词 内科学 幽门螺杆菌 冠心病 C反应蛋白 高脂血症 Helicobacter Pylori Coronary Heart Disease C-Reactive Protein Hyperlipidemia
  • 相关文献

参考文献11

  • 1陈新.幽门螺杆菌感染与冠状动脉疾病关系的Meta分析[J].中国动脉硬化杂志,2001,9(2):127-130. 被引量:20
  • 2郭新贵,王守东,林宪如.冠心病患者抗幽门螺杆菌抗体的检出及与冠心病危险因素的关系[J].中国动脉硬化杂志,2005,13(1):82-84. 被引量:18
  • 3陈星海,王育珊,王江滨.幽门螺杆菌感染诱发动脉粥样硬化的机制[J].中国免疫学杂志,2007,23(7):671-672. 被引量:16
  • 4Hoffmeister A,Rothenbacher D,Bode G,et al.Current infection with Helicobacter pylori,but not seropositivity to Chlamydia pneumoniae or cytomegalovirus,is associated with and atherogenic,modified lipid profile[J].Arterioscler Thromb Vasc Biol,2001,21(3):427-432.
  • 5Sung KC,Rhee EJ,Ryu SH,et al.Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults[J].Int J Cardiol,2005,102(3):411-417.
  • 6Kanbay M,Gur G,Yucel M,et al.Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels[J].Dig Dis Sci,2005,50(7):1228-231.
  • 7Chimienti G,Russo F,Lamanuzzi BL,et al.Helicobacter pylori is associated with modified lipid profile:impact on lipoprotein(a)[J]. Clin Biochem,2003,36(5):359-365.
  • 8潘巍巍,江珊.超敏C反应蛋白与动脉粥样硬化的研究进展[J].中国心血管病研究,2007,5(12):940-943. 被引量:31
  • 9Oshima T,Ozono R,Yano Y,et al.Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects[J].Am Coll Cardiol,2005,45(8):1219-222.
  • 10Saijo Y,Utsugi M,Yoshioka E,et al.Relationship Helicobacter pylori infection to arterial atiffness in Japanese subjects[J].Hypertens Res,2005,28(4):283-292.

二级参考文献43

  • 1吴进寿,洪华山.高血压与炎症关系的研究进展[J].中国临床药理学与治疗学,2006,11(2):136-140. 被引量:47
  • 2J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 3Murray L J,Atherosclerosis,2000年,149卷,379页
  • 4张经坤,中华流行病学杂志,1998年,19卷,1期,50页
  • 5Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J, 1994, 71: 437-439.
  • 6Stone AF, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J, Camm AJ, Northfield TC. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes:South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation, 2002, 106 (10): 1 219-223.
  • 7Frishman WH, Ismail AA. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol Rev, 2002, 10 (4): 199-210.
  • 8De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis, 2002, 160 (2): 457-463.
  • 9Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus,is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol, 2001, 21 (3): 427-432.
  • 10Famularo G, Trinchieri V, Santini G, De Simone C. Infections, atherosclerosis, and coronary heart disease. Ann Ital Med Int, 2000, 15 (2): 144-155.

共引文献68

同被引文献178

引证文献24

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部